Market Cap

Iterum Therapeutics plc Market Capitalization:

$27.0 Million

USD as of Jan. 1, 2024

business Iterum Therapeutics plc Company Profile

Iterum Therapeutics plc Main Stock Listing

NASDAQ: ITRM

Market Capitalization History of Iterum Therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Iterum Therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 $27.0 M 88.72%
Jan. 1, 2023 $14.3 M 235.28%
Jan. 1, 2022 $4.3 M -75.67%
Jan. 1, 2021 $17.5 M -39.22%
Jan. 1, 2020 $28.9 M -62.21%
Jan. 1, 2019 $76.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Iterum Therapeutics plc Categories

Ireland languages Healthcare languages Biotechnology
Ireland Healthcare Ireland Biotechnology

Stocks & Indices

Iterum Therapeutics plc has the following listings and related stock indices.


Stock: NASDAQ: ITRM

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.